Notably, the secretion of high-molecular-weight IGF-II has been detected in the serum of cancer patients, with a direct link to non-islet tumour cell hypoglycaemia—reviewed by Van Doorn et al. (2020) [257]. This evidence concerns the gene IGF2 and neoplasm.